Gemcitabine ‐based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non‐Hodgkin lymphoma: No difference in outcomes
ConclusionsThe GBM/GBC regimen is effective and well-tolerated, offering outcomes that are highly comparable to those in NHL patients conditioned with BEAM/BEAC, as demonstrated in a prognostically matched cohort.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Huimin Liu,
Hesong Zou,
Dandan Shan,
Wei Liu,
Wenyang Huang,
Weiwei Sui,
Shuhui Deng,
Tingyu Wang,
Rui Lv,
Mingwei Fu,
Yan Xu,
Shuhua Yi,
Gang An,
Yaozhong Zhao,
Lugui Qiu,
Dehui Zou Tags: RESEARCH ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Hematology | Hodgkin's Disease | Lymphoma | Non-Hodgkin's Lymphoma | Oral Cancer | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants